Comparing HR 546 → HRES 277 — Supporting the designation of May 2025 as "National Myos...

Struck = only in HR 546 · added = only in HRES 277.

Previous
Latest
LC 112 3266 House Resolution 546 th th th By:
[Congressional Bills 119th Congress] [From the U.S.
Representatives Hilton of the 48, Cooper of the 45 , Hawkins of the 27 , Mathiak of nd th the 82 , O’Steen of the 169 , and others A RESOLUTION Recognizing May 2025 as Myositis Awareness Month;
Government Publishing Office] [H.
and for other purposes.
Res.
WHEREAS, residents of Georgia are among those affected by myositis and other rare diseases, as nearly one in ten Americans have a rare disease;
277 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H.
and WHEREAS, idiopathic inflammatory myopathies, collectively referred to as myositis, are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation, pain, fatigue, and difficulty swallowing and can result in myositis-associated interstitial lung disease;
RES.
and WHEREAS, more research is needed to identify the causes of and treatments for myositis, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis;
277 Supporting the designation of May 2025 as ``National Myositis Awareness Month''.
and WHEREAS, myositis is difficult to diagnose, often leading to delayed treatment, and individuals with the disease frequently struggle to find healthcare providers with expertise in their condition;
_______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 31, 2025 Mr.
and H.
McCormick submitted the following resolution;
R.
which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Supporting the designation of May 2025 as ``National Myositis Awareness Month''.
546 - 1 - LC 112 3266 WHEREAS, all who suffer from myositis experience a reduced quality of life, and no cure hasbeenfound;lifeexpectancyisoftenshortened,particularlyforthosewithinclusionbody myositis, and women and people of color with all forms of myositis experience pronounced health disparities;
Whereas residents of the United States of America are among those affected by myositis and other rare diseases, with nearly 1 in 10 Americans having rare diseases;
and WHEREAS, the Myositis Association is the leading international patient advocacy organization serving the myositis community, focusing on patient services, education, research, and public awareness in the pursuit of a world without myositis.
Whereas idiopathic inflammatory myopathies (collectively referred to as myositis) are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation and other symptoms, such as pain, fatigue, and trouble swallowing, and can result in myositis- associated interstitial lung disease;
NOW,THEREFORE,BEITRESOLVEDBYTHEHOUSEOFREPRESENTATIVESthat the members of this body recognize May 2025 as Myositis Awareness Month.
Whereas more research is needed to identify the causes of and modes of treatments for the myositis group of diseases, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis;
BEITFURTHERRESOLVEDthattheClerkoftheHouseofRepresentativesisauthorized and directed to make appropriate copies of this resolution available for distribution to the public and the press.
Whereas myositis is difficult to diagnose which leads myositis patients to frequently experience delayed treatment and difficulty finding a health care provider with expertise in their condition;
H.
Whereas all who suffer with myositis experience reduced quality of life, particularly since no cure has been found and life expectancy is shortened, especially for those with inclusion body myositis, and women and people of color with all forms of myositis experience particularly pronounced health disparities;
R.
and Whereas public awareness and education campaigns on myositis detection and treatment are held during the month of May:
546 - 2 -
Now, therefore, be it Resolved, That the House of Representatives-- (1) supports the designation of ``National Myositis Awareness Month'';
(2) recognizes the importance of raising awareness about myositis and its impact on United States veterans and citizens;
and (3) encourages all people in the United States to become more informed about myositis and to support the individuals and families who are affected by these conditions.
<all>